ACUTA CAPITAL PARTNERS, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$4,318,000
-8.4%
170,000
-33.7%
1.25%
-45.4%
Q1 2020$4,712,000
-44.8%
256,500
-33.8%
2.28%
+8.0%
Q4 2019$8,537,000
+41.0%
387,500
+0.8%
2.11%
-1.8%
Q2 2019$6,056,000
+25.7%
384,500
+16.9%
2.15%
-6.0%
Q1 2019$4,817,000328,8252.29%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,930,237$85,373,00050.34%
RTW INVESTMENTS, LP 5,029,462$48,082,0004.58%
EcoR1 Capital, LLC 4,764,447$45,548,0004.57%
RA Capital Management 3,933,489$37,604,0002.88%
Cormorant Asset Management, LP 3,600,954$34,425,0002.57%
Omega Fund Management, LLC 223,457$2,136,0002.10%
Ghost Tree Capital, LLC 950,000$9,082,0001.84%
EMORY UNIVERSITY 246,411$2,356,0001.68%
Trustees of Princeton University 114,286$1,093,0001.63%
BRIDGER MANAGEMENT, LLC 1,226,820$11,728,0000.71%
View complete list of DICERNA PHARMACEUTICALS INC shareholders